Rosacea Linked to Higher Risk of Parkinson’s Onset in Danish Population Study
Patients with rosacea may be at an increased risk of new-onset Parkinson’s disease, according to a Danish population study, “…
Articles by Ana de Barros, PhD
International Stem Cell Corporation Initiates Parkinson’s Patient Enrollment in Phase 1 Trial
International Stem Cell Corporation is now enrolling patients in a Phase 1 clinical trial of its lead product candidate, ISC-hpNSC — human…
Parkinson’s Researchers Looking into Easiest and Best Ways of Diagnosing Disease in Early Stages
Early diagnosis and treatment of Parkinson’s disease (PD) are crucial to halting its progression, since the process of neuron destruction is…
Parkinson’s Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa
Zambon S.p.A. and partner Newron Pharmaceuticals S.p.A. have announced the expansion of its European market by launching Xadago…
Parkinson’s Researcher Awarded $50,000 to Develop At-home System for Monitoring Movement Disability
The Clinical and Translational Sciences Institute (CTSI) at Penn State awarded $50,000 to Harriet Nembhard, a professor of industrial…
Parkinson’s Treatment Linked to Higher Risk of Melanoma in Scientific Review
In a recent literature review, researchers from University of Minnesota Medical School in Minneapolis found a link between…
Search for Parkinson’s Disease Treatment Prompts Major Pharmaceuticals to Join Groundbreaking Consortium
Seven large pharmaceutical companies have joined a groundbreaking consortium to accelerate the development of safe and effective therapies for Parkinson’s…
New Parkinson’s Clinical Trial Will Evaluate Drug Already Approved for Respiratory Conditions
A new clinical trial for Parkinson’s disease will focus on a drug already approved for the treatment of respiratory…
Parkinson’s Study of Gene Therapy to Prolong Efficacy of Levodopa Now Recruiting Participants
University of Pittsburgh School of Medicine researchers are leading the second arm of a trial, now recruiting participants, that…
Neurons in Parkinson’s Patients May Be Taught to Respond to Placebos as Drugs
Brain cells in Parkinson’s disease patients can learn to respond to placebo drugs, although the training appears to wear off after…